Hypogonadism Completed Phase 2 Trials for Testosterone (DB00624)

IndicationStatusPhase
DBCOND0009256 (Hypogonadism)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00365794Effects of Testosterone Gel on Carbohydrate and Lipid Metabolism In Elderly Obese MenTreatment
NCT00104572Effects of Aromatase Inhibition Versus Testosterone in Older Men With Low Testosterone: Randomized-Controlled Trial.Treatment
NCT00975650Efficacy and Tolerability of an Intra-Nasal Testosterone ProductTreatment
NCT01252745Efficacy of an Intranasal Testosterone ProductTreatment
NCT0039858028-Day Study of Testosterone Co-administered With Dutasteride in Hypogonadal MenTreatment
NCT00080483Testosterone and Growth Hormone for Bone Loss in MenTreatment
NCT00141492Efficacy and Safety of Androgel in the Treatment of Hypogonadal and Low Testosterone Men With Type 2 DiabetesTreatment
NCT00161421Oral Androgens in Man-3 (ORAL T-3) Pharmacokinetics of Oral TestosteroneTreatment
NCT00372008Pharmacokinetics of Testosterone Lotion in the Treatment of Hypogonadal Males
NCT00647868NASOBOL in Hypogonadal Men in Comparison to Testosterone Levels in Normal Healthy Male VolunteersTreatment
NCT00857961A Study of the Pharmacokinetics of Testosterone Metered Dose (MD)-Lotion FormulationsTreatment
NCT01323140Pharmacokinetics, Metabolism, Efficacy, and Safety Study of Two Testosterone Matrix Transdermal SystemsTreatment
NCT01386567A One Year Open Label Study for the Treatment of Hypogonadism (Low Testosterone) in Men Who Have Completed ZA-203Treatment
NCT01419236A Study of Ejaculatory Dysfunction in Men With Low Testosterone LevelsTreatment
NCT01717768Oral Testosterone for the Treatment of HypogonadismTreatment
NCT02222558Oral Testosterone for the Treatment of Hypogonadism in MalesTreatment